Ignite Creation Date:
2024-07-17 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06465914
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-06-14
Brief Title:
A Phase III Study to Evaluate the Efficacy Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
Sponsor:
Shanghai Bovax Biotechnology Co Ltd
Organization:
Shanghai Bovax Biotechnology Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-11
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-07-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-14
First Submit QC Date:
None
Study First Post Date:
2024-06-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-11
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED